Page 1 of Clinical Trials for QLT Inc. [SPONSOR-COLLABORATORS], 37 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
Last Updated: March 25, 2011
Condition(s): Glaucoma; Ocular Hypertension
2
Terminated
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)
Last Updated: May 22, 2012
Condition(s): Stage IIIb Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
3
Terminated
A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
Last Updated: March 25, 2011
Condition(s): End Stage Renal Disease
4
Completed
Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Last Updated: March 25, 2011
Condition(s): Glaucoma; Ocular Hypertension
5
Completed
A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)
Last Updated: June 27, 2011
Condition(s): Open-Angle Glaucoma; Ocular Hypertension
6
Recruiting
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Last Updated: March 1, 2012
Condition(s): RP (Retinitis Pigmentosa)
7
Completed
Visudyne® in Occult (VIO)
Last Updated: July 19, 2005
Condition(s): Macular Degeneration
8
Completed
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
Last Updated: June 27, 2011
Condition(s): Glaucoma; Ocular Hypertension
9
Completed
Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia
Last Updated: May 22, 2012
Condition(s): Benign Prostatic Hyperplasia
10
Terminated
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)
Last Updated: May 22, 2012
Condition(s): Stage IIIb Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
11
Withdrawn
A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Last Updated: March 1, 2011
Condition(s): Glaucoma; Ocular Hypertension
12
Completed
Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers
Last Updated: March 27, 2009
Condition(s): Healthy Human Volunteers
13
Completed
Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer
Last Updated: May 22, 2012
Condition(s): Breast Neoplasms
14
Completed
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
Last Updated: June 27, 2011
Condition(s): Ocular Hypertension; Open-Angle Glaucoma
15
Terminated
A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
Last Updated: June 23, 2011
Condition(s): Seasonal Allergic Conjunctivitis to Ragweed
16
Active, not recruiting
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Last Updated: May 4, 2012
Condition(s): Glaucoma; Ocular Hypertension (OH)
17
Recruiting
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Last Updated: April 5, 2012
Condition(s): LCA (Leber Congenital Amaurosis); RP (Retinitis Pigmentosa)
18
Terminated
Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
Last Updated: March 1, 2011
Condition(s): Basal Cell Carcinoma; Nevoid Basal Cell Carcinoma Syndrome; Gorlin Syndrome
19
Terminated
Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
Last Updated: October 2, 2006
Condition(s): Prostatic Hyperplasia
20
Active, not recruiting
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Last Updated: May 4, 2012
Condition(s): Glaucoma; Ocular Hypertension (OH)

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=QLT+Inc.

Page 1 of Clinical Trials for QLT Inc. [SPONSOR-COLLABORATORS], 37 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About